Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization

<figure class="figure-group responsive"><div class="sub-figure" id="a"><object data="https://static.hindawi.com/articles/jitc/volume-2019/9691753/figures/9691753.fig.001a.svgz" name="9691753.fig.001a" type="image/svg+xml"></object><div class="fig-label">(a) Survival rates at 30 days</div></div><div class="sub-figure" id="b"><object data="https://static.hindawi.com/articles/jitc/volume-2019/9691753/figures/9691753.fig.001b.svgz" name="9691753.fig.001b" type="image/svg+xml"></object><div class="fig-label">(b) Freedom from MACCE rates at 30 days</div></div></figure>

<p>Kaplan-Meier analysis of estimated 30-day survival rate and freedom from MACCE rate. MACCE: major adverse cardiac and cerebrovascular events (death, stroke, myocardial infarction, and repeat revascularization).</p>

Journal of Interventional Cardiology

fig1

Figure 1

Figure 1: Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization 

Figure 1 | Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization 